Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
27 March 2023 - 11:00PM
Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage
pharmaceutical company that aims to discover and develop medicines
that are transformational for patients, today announced that
members of its management team will participate in the following
investor conferences:
Event: Guggenheim Genomic Medicines and
Rare Disease DaysDate: Monday, April 3,
2023Location: New York, NYFireside
Chat: 9:35 AM ET
Event: Jefferies & Venrock Boston Biotech
SummitDate: Wednesday, April 12, 2023
Where applicable, the presentation slides and/or a link to the
live webcast of the event, as well as an archived recording, will
be available under the “Events and Publications” tab on the
investor relations section of the Centessa Pharmaceuticals website
at https://investors.centessa.com/events-presentations.
About Centessa
PharmaceuticalsCentessa Pharmaceuticals plc is a
clinical-stage pharmaceutical company that aims to discover and
develop medicines that are transformational for patients. Our
programs span discovery-stage to late-stage development and cover a
range of high-value indications. We operate with the conviction
that each one of our programs has the potential to change the
current treatment paradigm and establish a new standard of care.
For more information, visit http://www.centessa.com/, which does
not form part of this release.
Contact:Kristen K. Sheppard, Esq.SVP of Investor
Relationsinvestors@centessa.com
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart
From Aug 2023 to Aug 2024